High-frequency, low-tidal-volume ventilation tied to catheter ablation success for atrial fibrillation: JACC

Written By :  Medha Baranwal
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-06-24 06:00 GMT   |   Update On 2023-06-24 11:04 GMT

USA: High-frequency, low-tidal-volume (HFLTV) ventilation during catheter ablation of paroxysmal atrial fibrillation (PAF) improves 12-month clinical outcomes, as shown by registry data across 12 institutions.

Following implementing HFLTV ventilation during the procedure, the researchers observed freedom from all-atrial arrhythmia recurrence, AF-related symptoms, and atrial fibrillation-related hospitalizations with shorter procedural times. The findings from the study were published in JACC: Clinical Electrophysiology.

High-frequency, low-tidal volume is a simple and safe strategy to improve first-pass isolation and catheter stability during pulmonary vein (PV) isolation. However, the impact of this technique on long-term clinical outcomes has yet to be investigated. Therefore, Jose Osorio, Arrhythmia Institute at Grandview, Birmingham, Alabama, USA, and colleagues sought to evaluate acute and long-term outcomes of HFLTV ventilation compared with standard ventilation (SV) during radiofrequency (RF) ablation of paroxysmal atrial fibrillation.

Advertisement

A standard ventilation protocol typically employs high tidal volumes with low respiratory rates during catheter ablation. In contrast, HFLTV ventilation minimizes the downward shift of the diaphragm during inspiration, which may improve catheter stability and boosts first-pass isolation during pulmonary vein isolation (PVI).

The prospective multicenter registry (REAL-AF) included patients undergoing PAF ablation using standard ventilation or HFLTV. The study's primary outcome was 12 months of freedom from all-atrial arrhythmia. Secondary outcomes were AF-related symptoms, procedural characteristics, and hospitalizations at 12 months.

The study revealed the following findings:

  • A total of 661 patients were included. Compared with those in the SV group, patients in the HFLTV group had shorter procedural (66 minutes versus 80 minutes), total RF (13.5 minutes versus 19.9 minutes), and PV RF (11.1 minutes versus 15.3 minutes) times.
  • First-pass PV isolation was higher in the HFLTV group (66.6% vs 63.8%).
  • At 12 months, 85.6% of patients in the HFLTV group were free from all-atrial arrhythmia, compared with 79.3% of patients in the SV group.
  • HLTV was associated with a 6.3% absolute reduction in all-atrial arrhythmia recurrence, a lower rate of AF-related symptoms (12.5% versus 18.9%), and hospitalizations (1.4% versus 4.7%).
  • There was no significant difference in the rate of complications.

"HFLTV ventilation during catheter ablation of paroxysmal atrial fibrillation improved freedom from all-atrial arrhythmia recurrence, atrial fibrillation-related symptoms, and AF-related hospitalizations with shorter procedural times," the researchers wrote.

"Future research may compare HFLTV ventilation with high-frequency jet ventilation, which is also anticipated to increase catheter stability -- albeit with costly special equipment," they concluded.

Reference:

Osorio J, Zei PC, Díaz JC, Varley AL, Morales GX, Silverstein JR, Oza SR, D'Souza B, Singh D, Moretta A, Metzl MD, Hoyos C, Matos CD, Rivera E, Magnano A, Salam T, Nazari J, Thorne C, Costea A, Thosani A, Rajendra A, Romero JE. High-Frequency Low-Tidal-Volume Ventilation Improves Long-Term Outcomes in Atrial Fibrillation Ablation: A Multicenter Prospective Study. JACC Clin Electrophysiol. 2023 May 18:S2405-500X(23)00298-0. doi: 10.1016/j.jacep.2023.05.015. Epub ahead of print. PMID: 37294263.


Tags:    
Article Source : JACC: Clinical Electrophysiology

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News